文章摘要
应春雷,曹中,赵韧,王邦宁.血脂康治疗中青年代谢综合征患者疗效观察[J].中国临床保健杂志,2019,22(4):538-541.
血脂康治疗中青年代谢综合征患者疗效观察
Effect observation of Xuezhikang in treating metabolic syndrome among young and middle-aged patients
投稿时间:2019-03-01  
DOI:10.3969/J.issn.1672-6790.2019.04.028
中文关键词: 代谢综合征  早期医疗干预  生活方式  中年人  青年人
英文关键词: Metabolic syndrome  Early medical intervention  Life style  Middle aged  Young adult 〖FL
基金项目:安徽省自然科学基金(1508085QH164);安徽医科大学第一附属医院横向课题基金(5201001002-8070)
作者单位E-mail
应春雷 安徽医科大学第一附属医院心血管内科,合肥 230022 wangbangning@medmail.com.cn 
曹中 安徽医科大学第一附属医院心血管内科,合肥 230022 wangbangning@medmail.com.cn 
赵韧 安徽医科大学第一附属医院心血管内科,合肥 230022 wangbangning@medmail.com.cn 
王邦宁 安徽医科大学第一附属医院心血管内科,合肥 230022 wangbangning@medmail.com.cn 
摘要点击次数: 109
全文下载次数: 92
中文摘要:
      目的 观察血脂康对中青年代谢综合征患者的治疗效果。 方法 入组的80例中青年代谢综合征患者在生活方式干预的基础上给予血脂康(0.6克/次,2次/天)治疗24周,观察治疗前后腹围、体质指数、血压、空腹血糖(FPG)、血脂、载脂蛋白B/载脂蛋白A比值(ApoB/ApoA)、空腹胰岛素(FIns)、胰岛素抵抗指数(HOMA-IR)、超敏C反应蛋白(hs-CRP)及尿酸(UA)的变化。 结果 治疗后腹围、体质指数、总胆固醇、低密度脂蛋白胆固醇、ApoB/ApoA、hs-CRP、UA等指标均较前下降(P<0.05),高密度脂蛋白胆固醇较前升高(P<0.05);血清hs-CRP和UA水平随着中青年代谢综合征患者符合诊断标准个数的增加而升高(P<0.05);符合各单项诊断标准组血清hs-CRP和UA水平较不符合组也相应有所增加(P<0.05)。 结论 血脂康能改善中青年代谢综合征患者的异常代谢指标,对早期预防心血管疾病的发生发展可能有效。
英文摘要:
      Objective To observe the intervention effect of Xuezhikang on young and middle-aged patients with metabolic syndrome(MS). Methods Eighty young and middle-aged patients with metabolic syndrome were given Xuezhikang(0.6 g/time,2 times/day )for 24 weeks on the basis of lifestyle intervention,the changes of waist circumference,body mass index(BMI),blood pressure,fasting blood glucose(FPG),apolipoprotein B / apolipoprotein A ratio(ApoB / ApoA),fasting insulin(FIns),homeostasis model assessment for insulin resistance index(HOMA-IR),high-sensitivity C reactive protein(hs-CRP) and uric acid(UA)were observed before and after treatment. Results There was significant difference in waist circumference,BMI,systolic blood pressure(SBP),total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),ApoB/ApoA,HOMA-IR,hs-CRP,UA and HDL-C before and after trentment.The serum levels of hs-CRP and UA increased with the increase of the number of diagnostic criteria in young and middle-aged patients with metabolic syndrome (P<0.05).When each component reached the diagnostic criteria of metabolic syndrome,the serum hs-CRP and UA levels also increased significantly. Conclusion Xuezhikang can improve the abnormal metabolic indexes of young and middle-aged patients with MS,and may be effective in preventing the occurrence and development of cardiovascular diseases in the early stage.
查看全文     下载PDF阅读器
关闭
分享按钮